|
Join us for a roundup of the 2020 ESC congress, discussing all the latest data related to diabetes and how it should impact practice.
Featuring interviews with:
- Professor Lars Ryden, discussing a subgroup analysis of REWIND
- Dr Naveed Sattar, discussing pooled analysis of SUSTAIN 6 and PIONEER 6
This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education. |